Articles Published in 2013

URAC launches two accreditation programs

Friday, September 6, 2013 02:50 PM

Recent healthcare reform efforts are focused on transforming care delivery while also controlling skyrocketing costs. URAC, an independent accreditation organization advancing quality and value throughout healthcare, has launched two new accreditation programs for Clinical Integration and Accountable Care.

More... »

Focused Ultrasound Foundation to launch research initiative

Friday, September 6, 2013 02:45 PM

The Focused Ultrasound Foundation and Royal Philips have entered into a public-private collaboration with The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust. The partnership will create a focal point for ultrasound therapy research at ICR and The Royal Marsden in London under the international Focused Ultrasound Foundation Centers of Excellence Program.

More... »

Ximedica, Theorem collaborate

Friday, September 6, 2013 02:44 PM

Global CRO Theorem Clinical Research is collaborating with Ximedica, a medical product development firm.

More... »

Almac partners for cancer research in Northern Ireland

Friday, September 6, 2013 02:42 PM

Almac Discovery has announced a $20.2million partnership with the Center for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused drug discovery in Northern Ireland.

More... »

Sensus Healthcare appoints Mark Nestor clinical director

Wednesday, September 4, 2013 04:02 PM

Sensus Healthcare has appointed Dr. Mark Nestor clinical director. Nestor joins a panel of medical advisory board members. He will lead the company's efforts in training, education and clinical research as the company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars.

More... »

Karen M. Emmons named VP, director of Kaiser Foundation Research Institute

Wednesday, September 4, 2013 04:00 PM

Kaiser Permanente, a health research organization, has named Karen M. Emmons, Ph.D., associate dean for research at the Harvard School of Public Health, vice president for research and director of the Kaiser Foundation Research Institute, effective Sept. 30.

More... »

Accelrys acquires ChemSW

Wednesday, September 4, 2013 03:59 PM

Accelrys, a provider of scientific innovation lifecycle management software, has acquired ChemSW, an Environmental Health & Safety (EH&S) compliance solutions provider. This acquisition furthers Accelrys' scientific innovation lifecycle management strategy by providing solutions for managing and tracking the source, use and disposal of chemicals along the entire lab-to-plant value chain.

More... »

Heidelberg Pharma, Roche ink license agreement

Wednesday, September 4, 2013 03:57 PM

Germany-based Heidelberg Pharma, a wholly owned subsidiary of Wilex, has signed a license agreement with Roche covering the development of a novel class of antibody drug conjugates (ADCs) based on Heidelberg Pharma’s patented technology to couple α-Amanitin to antibodies. The license agreement covers initial joint research to apply this technology to multiple Roche antibodies towards the identification of development candidates with favorable efficacy/safety profiles.

More... »

Enanta receives additional $9.2m funding from NIAID

Wednesday, September 4, 2013 03:54 PM

The National Institute of Allergy and Infectious Diseases (NIAID), a division of the NIH, has agreed to provide additional funding of $9.2 million to its existing contract with Enanta Pharmaceuticals, an R&D-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, to fund preclinical and early clinical development for a new class of bridged bicyclic antibiotics known as Bicyclolides.

More... »

Mylan receives approval from India, acquires Agila

Wednesday, September 4, 2013 03:53 PM

Global pharmaceutical company Mylan’s proposed acquisition of the Agila injectables businesses from Indian pharmaceutical company Strides Arcolab has received approval from India's Foreign Investment Promotion Board (FIPB). The transaction also received approval from the Cabinet Committee on Economic Affairs (CCEA). The transaction is expected to close in the fourth quarter of 2013.

More... »